Peter H. O'Donnell to Melphalan
This is a "connection" page, showing publications Peter H. O'Donnell has written about Melphalan.
Connection Strength
0.097
-
Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2012 Jun; 18(6):913-21.
Score: 0.097